MedPath

PAN Foundation Study Reveals 'C' Grade for U.S. Healthcare Access, Highlighting Systemic Disparities

  • A comprehensive national survey by PAN Foundation gives U.S. healthcare access a 'C' grade (75.8), revealing significant barriers particularly affecting marginalized communities and chronic disease patients.

  • Insurance-related treatment access received a concerning 'D-' grade (62.8), with Hispanic, Native American, Pacific Islander, and LGBTQIA+ patients experiencing the most severe challenges.

  • The study found that 36% of patients had to take financial measures to afford medications, while 48% faced logistical barriers in accessing care, demonstrating widespread healthcare accessibility issues.

The Patient Access Network (PAN) Foundation has released a groundbreaking report revealing significant challenges in U.S. healthcare access, particularly among patients with chronic conditions. The comprehensive analysis, based on extensive national surveys, assigns an overall 'C' grade to the state of healthcare access in America, highlighting deep-rooted disparities across various demographic groups.

Healthcare Access Disparities Across Key Metrics

The research, conducted through The Harris Poll between August and September 2023, surveyed 2,502 patients with chronic conditions and 501 healthcare providers. The study evaluated five crucial areas of healthcare access, revealing concerning patterns of inequality and systemic barriers.
Overall access to care earned a 'C+' (78.8), with 48% of patients reporting logistical barriers to accessing healthcare services. These challenges were particularly pronounced among specific demographics:
  • 77% of LGBTQIA+ patients reported access barriers
  • 70% of younger patients faced significant obstacles
  • 57% of people of color encountered logistical challenges

Insurance Coverage and Financial Toxicity

The most alarming findings centered on insurance-related treatment access, which received a 'D-' grade (62.8). The situation was even more dire for certain populations:
  • Hispanic, Native American, and Pacific Islander patients received an 'F' grade
  • LGBTQIA+ individuals and lower-income patients also scored failing grades
  • Financial toxicity earned a 'C-' (70.7), with marginalized communities bearing the heaviest burden

Medication Affordability and Provider Relations

Despite relatively better performance in some areas, significant challenges persist:
  • Prescription medicine affordability received a 'B-' (82.3)
  • 20% of patients reported their prescriptions were unaffordable
  • 36% had to take financial measures, including reducing spending or incurring credit card debt, to afford medications
  • Provider relationships scored a 'B' (84.2), with 96% of patients expressing trust in their healthcare professionals

Impact on Marginalized Communities

The report particularly emphasizes the disproportionate impact on historically underserved populations:
  • People of color reported 31% higher levels of financial toxicity
  • LGBTQIA+ patients experienced 41% higher financial burden
  • Younger patients faced 36% higher levels of financial strain
"Health care in the United States has become unaffordable and inaccessible for many patients, even those with health insurance and other resources," the report states, attributing these disparities to deeply rooted systemic issues including racism, bias, structural inequities, and economic disadvantages.

Future Implications and Initiatives

The PAN Foundation has launched the State of Patient Access initiative as part of its new Center for Patient Research, aiming to track and improve healthcare access metrics over time. The organization emphasizes its commitment to continued advocacy until equitable, affordable healthcare becomes a reality for all Americans.
This comprehensive assessment serves as a crucial tool for policymakers, advocacy groups, and healthcare leaders, providing clear evidence of the need for systematic changes to address healthcare access disparities in the United States.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

© Copyright 2025. All Rights Reserved by MedPath